| NOVN |
| ISIN | CH0012005267 |
| シンボル | NOVN |
| 取引所 | EUREX |
| 種類 | オプション |
Options
| Exp. date | 種類 | 種類 |
|---|---|---|
| 3/21 | 44 Calls | 43 Puts |
| 4/21 | 33 Calls | 33 Puts |
| 5/21 | 27 Calls | 27 Puts |
| 6/21 | 39 Calls | 38 Puts |
| 9/21 | 31 Calls | 31 Puts |
| 12/21 | 44 Calls | 44 Puts |
| 6/22 | 14 Calls | 14 Puts |
| 12/22 | 12 Calls | 12 Puts |
| 6/23 | 9 Calls | 9 Puts |
| 12/23 | 10 Calls | 10 Puts |
| 12/24 | 10 Calls | 10 Puts |
| 12/25 | 8 Calls | 8 Puts |
Puts
| Strike | 直近 | Open Interest | |
|---|---|---|---|
| 52,00 | 1,20 | 5.250 | |
| 60,00 | 2,60 | 14.016 | |
| 64,00 | 4,12 | 1.864 | |
| 68,00 | 4,70 | 10.169 | |
| 76,00 | 8,20 | 8.743 | |
| 84,00 | 14,00 | 7.484 | |
| 92,00 | 22,00 | 1.050 | |
| 100,00 | 21,20 | 20 |
ニュース
- National Lipid Association and Paradigm Medical Communications, LLC Announce Collaborative Partnership in Lipids Education
15:00 - GlobeNewswire - Ayala Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
14:00 - GlobeNewswire - Lisa Deschamps Joins Verona Pharma as Non-Executive Director
08:00 - GlobeNewswire - Novartis Entresto® granted expanded indication in chronic heart failure by FDA
16.02.2021 / 19:22 - GlobeNewswire - Novartis signs initial deal to manufacture Pfizer jabs
29.01.2021 / 13:04 - TeleTrader